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Case Report
Mixed Epithelial and Stromal Tumor of the Kidney
With Elevated Serum Level of Cancer Antigen 125
Chih-Hsin Liu,1 Chia-Cheng Yu,2* Chao-Ren Chang,2 Tony T. Wu,2 Jong-Khing Huang2
Mixed epithelial and stromal tumor of the kidney is a newly categorized lesion, with few reported cases.
We report a rare case of a 45-year-old woman with a palpable abdominal mass and elevated serum level of
serum cancer antigen 125, who was not receiving hormones or contraceptive agents. Abdominal magnetic
resonance imaging revealed a large multilocular cystic tumor that arose in the left central kidney. Nephrec-
tomy was performed under the initial impression of cystic renal cell carcinoma; however, a diagnosis of
mixed epithelial and stromal tumor was confirmed according to pathological and immunohistochemical
findings. Serum level of cancer antigen 125 returned to normal after 1 month postoperatively, and no 
recurrence was found in the following 18 months.
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Mixed epithelial and stromal tumor of the kidney
(MESTK) is a rare and complex tumor that occurs
mostly in middle-aged women. To date, there have
only been about 70 cases reported worldwide. In
this article, we present a 45-year-old woman with
MESTK, who had no history of iatrogenic hor-
mone use. We suggest that serum cancer antigen
(CA)-125 plays an important role in the diagnosis
and postoperative follow-up.
Case Report
A 45-year-old perimenopausal woman was referred
because of a large cystic tumor that originated
from the pancreatic tail or the left kidney, which
was found by abdominal computed tomography
at a local hospital. Abdominal fullness was inter-
mittently observed for about 1 year and a palpa-
ble abdominal mass was noted more recently.
Tracing back her history, she underwent uterine
myomectomy 6 years ago, besides which, she had
received no exogenous hormonal treatment for
any other reason at any other time.
Preoperative biochemical and hematological
surveys, including renal function tests, were all
within normal ranges (blood urea nitrogen/
creatinine: 15/0.8 mg/dL), except for elevated
serum level of CA-125 (63.76 U/mL; normal:
< 35.0 U/mL). Otherwise, we noted no flank
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pain, gross hematuria, or other endometriosis-
associated symptoms, including dysmenorrhea
and dyspareunia. Abdominal magnetic resonance
imaging revealed a large multilocular cystic tumor
that was derived from the ventral cortex of the
left central kidney (Figure 1), which was initially
considered to be cystic nephroma (CN) or cystic
renal cell carcinoma (RCC).
This large, centrally located renal tumor was
poorly demarcated from its neighboring paren-
chyma, and the possibility of a malignant renal
tumor could not be excluded; therefore, we per-
formed a left radical nephrectomy to completely
remove the tumor. The excised specimen was
16 × 13 × 9.5 cm and consisted of an ivory-white,
mixed multicystic and solid tumor without necro-
sis (Figure 2). Microscopic assessment revealed a
multilocular cystic lesion that was lined by a
columnar or cuboidal epithelium (Figure 3A),
and occasionally, this epithelial layer appeared
as small papillary tufts that were called “hobnail
cells” (Figure 3B). Among the cysts, ovarian-type
stroma was composed of mixed solid parts.
Meanswhile, in most fields under the microscope,
the paucicellular part and the cellular part formed
by spindle cells were presented simultaneously in
one picture. Some complex branching channels in
the stroma containing focal cellular parts (formed
majorly spindle cells) were also found. Further-
more, immunohistochemical staining showed that
the stromal cells were positive for estrogen recep-
tor, progesterone receptor, and smooth muscle
markers (HHF-35 and desmin) (Figures 3C–F).
Therefore, a diagnosis of MESTK was confirmed.
The postoperative course was uneventful and
the patient was discharged on postoperative day 5.
During postoperative follow-up, serum CA-125 re-
turned to normal after 1 month, and there was no
tumor recurrence or metastasis during 18 months
postoperative follow-up.
Discussion
Michal and Syrucek1 initially defined the term
MESTK to demonstrate the biphasic morphology
of this tumor, which comprises both cystic and
solid components. In 2000, Adsay et al2 de-
scribed the immunohistochemical characteristics
of this newly categorized neoplasm and suggested
the possible hormonal role in tumor formation.
Recently, Turbiner et al3 compared MESTK with
cystic nephroma and coined a new term, renal
epithelial and stromal tumor, to encompass both
MESTK and CN according to their similarities, 
although there are still some differences between
them. MESTK, as in our case, is basically benign
and frequently occurs in perimenopausal women
(mean age: 52 years).3 To date, there have been
only three male cases of MESTK.2,4–6 The clinical
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Figure 1. T2-weighted coronal magnetic resonance imag-
ing showed a well-circumscribed and multicystic tumor
that originated from the left kidney.
Figure 2. The excised specimen consisted of an ivory-white,
mixed multicystic and solid tumor without necrosis.
Kidney mixed epithelial and stromal tumor
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presentation of MESTK includes abdominal mass,
flank pain, hematuria, and urinary tract infection.7
Based on the 2004 World Health Organization
classification of adult renal tumors,8 MESTK is
defined as a complex tumor composed of mul-
tilocular cysts lined by columnar or cuboidal 
epithelium, thicker cystic septa (≥5 mm micro-
scopically; the major difference from CN), and
ovarian-type stroma which is formed of variable
spindle cells. Most reported cases of MESTK show
benign histological features and clinical course;
however, there have been reports of nine cases of
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Figure 3. (A) MESTK was composed of complex multilocular cysts and gland-enriched stromal areas (hematoxylin & eosin,
original magnification 40×). (B) At high power, the cyst was lined by columnar, cuboidal, or flattened epithelium, which
partially formed small papillary tufts (hobnail cells) (hematoxylin & eosin, original magnification 400×). (C) Estrogen 
receptors and (D) progesterone receptors were seen in the nuclei of the stromal cells of MESTK (original magnification
100×). Smooth muscle markers such as (E) HHF-35 and (F) desmin were also seen in the stromal area of MESTK (original
magnification 100×). MESTK = Mixed epithelial and stromal tumor of the kidney.
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MESTK with malignant transformation.9–11 Eight
of these were found to contain sarcomatous com-
ponents in the stroma, and the other had rhab-
doid features.11
To date, opinions about the pathogenesis of
MESTK are controversial. Through a study of the
ovarian-type stroma in pancreatic mucinous cystic
tumors, Izumo et al12 have found that the simi-
larity between the ovarian-type and true ovarian
stroma included inhibin-positive luteinized cells
and stromal positivity for estrogen and proges-
terone receptors. These similarities could also pro-
vide embryological clues to the origin of tumors
with ovarian-type stroma, such as MESTK, hepa-
tobiliary cystadenoma, pancreatic mucinous cys-
tic tumor, and primary retroperitoneal mucinous
cystadenocarcinoma. The formation of MESTK has
two possible hypotheses. One is the fetal primitive
mesenchyme in the kidney, which could be hy-
perstimulated by hormonal imbalance. The other
is that the ovarian stromal cells migrate to the
ureteric bud and metanephric mesoderm during
embryogenesis. In our study, abnormal elevation
of CA-125 provided evidence to support both
these hypotheses.
It is difficult to distinguish MESTK from CN
and cystic RCC preoperatively by radiographic
assessment because of their gross morphological
similarities. Also, percutaneous renal biopsy gives
a limited sample and increases the possible risk of
extension of malignant cells, especially if the cys-
tic RCC is pathologically confirmed later from
the surgical specimen. Hence, a definite diagno-
sis ought to be based on the pathological results.
In the present case, radical nephrectomy was car-
ried out because it is technically difficult to re-
move completely the poorly demarcated tumor
and preserve the function of the remnant kidney
simultaneously. However, based on the relatively
benign nature of MESTK and recent changes in sur-
gical intervention for small RCC, we suggest that
nephron-sparing surgery can still be regarded as
the first-choice treatment of MESTK.
In conclusion, MESTK is a rare, female-
predominant neoplasm with complex cystic and
solid components. Only a few malignant cases
have been reported. In our case, serum CA-125
level played an important role in diagnosis and
postoperative follow-up. Moreover, the abnormal
elevation of CA-125 also supports the current 
hypotheses about the pathogenesis of MESTK. Due
to the relatively low possibility of malignancy,
nephron-sparing surgery can be considered as the
treatment of choice, if technically feasible.
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